University of California, Berkeley
Kyle E. Giesler is a postdoctoral scholar at the University of California, Berkeley investigating non-viral delivery strategies for CRISPR/Cas9. He received his Ph.D. in medicinal chemistry from Emory University under the tutelage of Dennis Liotta. At Emory, he designed novel small molecules for the treatment of HIV and other chronic viral infections. From 2015 to 2017, he interned with the former Senior Vice President and Chief Patent Counsel at GlaxoSmithKline, Sherry Knowles. His research interests include drug delivery and high-risk drug discovery ventures to develop cutting-edge therapies for the treatment of human disease.
The appearance of an author or a presenter on this DTIC website should not necessarily be construed as association of this individual with the United States Department of Defense (DoD), and the views, information, or opinions expressed herein are those of the author or presenter and do not necessarily constitute endorsement by the United States Department of Defense (DoD).